Generated by GPT-5-mini| Tris (buffer) | |
|---|---|
| Name | Tris |
| IUPAC name | 2-amino-2-(hydroxymethyl)propane-1,3-diol |
| Other names | tris(hydroxymethyl)aminomethane; THAM |
| Formula | C4H11NO3 |
| Molar mass | 121.14 g·mol−1 |
| Appearance | white crystalline powder |
| Melting point | 171–172 °C (decomp.) |
| Solubility | soluble in water |
Tris (buffer)
Tris (IUPAC: 2-amino-2-(hydroxymethyl)propane-1,3-diol), commonly called tris(hydroxymethyl)aminomethane or THAM, is an organic compound widely used as a biochemical buffer. It is a white crystalline amine-alcohol that provides effective pH control near physiological values, and appears in protocols across molecular biology, biochemistry, and clinical chemistry. Tris is notable for its role in electrophoresis, enzymology, and tissue culture where stable buffering around neutral pH is required.
Tris is an aliphatic primary amine bearing three hydroxymethyl substituents, giving it both basicity and multiple hydrogen-bonding donors; its molecular structure determines solubility and reactivity. The compound is zwitterion-capable under certain protonation states and exhibits nucleophilicity typical of primary amines, which can engage in Schiff base formation and react with carbonyl-containing reagents; related behaviors are seen with Ethylenediaminetetraacetic acid, N,N-dimethylformamide, Sodium hydroxide, Hydrochloric acid, and Acetic acid in laboratory manipulations. Tris has limited volatility, a relatively high melting point, and thermal decomposition pathways similar to other small polyols and amines used in Pharmaceutical industry and Chemical synthesis.
Tris is synthesized industrially by the condensation of formaldehyde with ammonia followed by hydrogenation or by alkylation routes starting from isobutylene and ammonia under controlled conditions, analogous in part to processes used for producing other amine-alcohols like Morpholine and Triethanolamine. Commercial preparations often include buffers salts such as Tris·HCl, and derivatized forms include methylated or sulfonated analogs used in specialty applications, drawing parallels to derivatives of Imidazole and Glycine used in buffer families. Protective derivatives for peptide coupling and modified Tris reagents for chromatography have been developed in laboratories associated with Max Planck Institute, Salk Institute, and academic groups at Harvard University and University of Cambridge working on bioconjugation chemistry.
Tris has a pKa of approximately 8.06 at 25 °C, making it most effective for buffering between pH 7 and 9; this pKa is sensitive to temperature and ionic strength changes similarly to the pKa shifts observed with Imidazole and Phosphate buffer systems. The buffering range and capacity depend on concentration, salt composition (e.g., Sodium chloride, Potassium chloride), and temperature; adjustments are often performed by titration with acids or bases such as Hydrochloric acid or Sodium hydroxide in protocols derived from methods developed at institutions like National Institutes of Health and European Molecular Biology Laboratory. The temperature coefficient (ΔpKa/°C) is notable and mandates temperature control during assays, as with buffers used by researchers at Cold Spring Harbor Laboratory and Lawrence Berkeley National Laboratory.
Tris is ubiquitous in buffers for electrophoresis (e.g., Tris-glycine, Tris-borate-EDTA) employed in techniques standardized by groups at Rockefeller University and Stanford University, in nucleic acid extraction and storage as used in protocols from Addgene and New England Biolabs, and in enzymatic assays where near-neutral pH is required, paralleling applications of Tricine and HEPES. It is a component of many commercial reagent kits distributed by companies such as Thermo Fisher Scientific, Sigma-Aldrich, and Qiagen and appears in cell culture media formulations and physiological saline preparations in clinical settings influenced by practice at Mayo Clinic and Cleveland Clinic. Tris buffers are also used in immunoassays and western blotting protocols developed by laboratories at Johns Hopkins University and Boston University.
Tris can interact with biological molecules: it may perturb enzyme kinetics, bind metal ions, and interfere with reactions involving activated carbonyls or isothiocyanates; such effects have been documented alongside interactions observed for EDTA and DTT in biochemical literature from University of Oxford and ETH Zurich. At high concentrations Tris alters osmolarity and can impact cell viability in in vitro systems, an effect monitored in studies from Scripps Research and Karolinska Institute. Safety considerations include standard chemical handling precautions consistent with guidelines from Occupational Safety and Health Administration and European Chemicals Agency; Tris solutions are of low acute toxicity but should be handled to avoid inhalation, ingestion, and skin contact, with disposal in accordance with institutional policies at facilities like University of California, Berkeley and Imperial College London.
Analytically, Tris can interfere with colorimetric assays, mass spectrometry ionization, and peptide mapping due to its primary amine and hydroxyl groups, similar to analyte suppression issues reported for Guanidine hydrochloride and SDS in proteomics workflows from Max Delbrück Center and ProteomeXchange partners. Tris forms complexes with certain metal ions affecting chelation equilibria assessed in studies from Argonne National Laboratory and Brookhaven National Laboratory; it also participates in buffer exchange and dialysis considerations employed in structural biology efforts at European Synchrotron Radiation Facility and Diamond Light Source. Selecting alternate buffers like MES, MOPS, or HEPES is common when Tris reactivity or interference compromises analytical outcomes in workflows developed at Cold Spring Harbor Laboratory and Broad Institute.
Category:Buffers